YOKNE’AM ILLIT, Israel, March 12, 2026 (GLOBE NEWSWIRE)-- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in artificial ...
Orforglipron's launch and Medicare/Medicaid eligibility will expand Eli Lilly's addressable market and offset price erosion.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果